Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB(1)) receptors are potent analgesics devoid of tolerance

Given that mu opioid (MOP) and canabinoid (CB(1)) receptors are co-localized in various regions of the CNS and have been reported to associate as heteromer (MOP-CB(1)) in cultured cells has raised the possibility of functional, endogenous MOP-CB(1) in nociception and other pharmacologic effects. As...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naour, Morgan Le, Akgün, Eyup, Yekkirala, Ajay, Lunzer, Mary M., Powers, Mike D., Kalyuzhny, Alexander E., Portoghese, Philip S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3849126/
https://ncbi.nlm.nih.gov/pubmed/23734559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm4005219
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares